FIELD: biochemistry.
SUBSTANCE: present invention relates to clinical biochemistry and can be used for separation and analysis of cholesterol of multiply modified low-density lipoproteins (mmLDL) in human blood serum. Method consists in the following: blood serum is treated with 20% buffer solution of polyvinyl pyrrolidone with the molecular weight 35,000 polyvinylpyrrolidone (PVP-35000) at the volume ratio of serum: PVP (1.0:0.84), followed by incubation for 10 minutes at room temperature, mmLDL units are deposited by centrifugation at 9,000 rpm for 10 min at 23 °C, the residue is decanted, mmLDL is dissolved in the buffer without PVP-35,000 and the cholesterol in the precipitate is determined. If the level of content of cholesterol in mmLDL is more than 6.6 mg/dl, the individual has a high level of mmLDL.
EFFECT: invention can be used to establish the presence of subclinical atherosclerosis in an examined individual, assess the severity of pathological process and develop the prognostic criteria of vascular complications.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING LYSIS MULTIPLE MODIFIED LOW DENSITY LIPOPROTEIN | 2015 |
|
RU2577719C1 |
METHOD FOR SELECTION AND STUDY OF ATHEROGENICITY OF IMMUNE COMPLEXES CONTAINING MULTIPLE MODIFIED LIPOPROTEINS | 2016 |
|
RU2632118C1 |
METHOD FOR RAPID DETERMINATION OF RESISTANCE TO LDL OXIDATION OF HUMAN SERUM | 2015 |
|
RU2578027C1 |
METHOD OF DETERMINATION OF ATHEROGENICITY OF IMMUNE COMPLEXES | 2013 |
|
RU2549467C1 |
METHOD FOR ASSESSING CHARACTER OF AUTOIMMUNE REACTION OF HUMAN BODY TO MULTIPLE MODIFIED LOW-DENSITY LIPOPROTEINS IN LYTIC TEST | 2017 |
|
RU2680848C1 |
METHOD FOR MEASURING THE CONCENTRATION OF CIRCULATING MODIFIED LOW-DENSITY LIPOPROTEINS IN HUMAN BLOOD SERUM | 2016 |
|
RU2659211C2 |
METHOD TO DETERMINE ATHEROGENICITY OF HUMAN BLOOD | 2012 |
|
RU2497116C1 |
METHOD FOR RAPID ANALYSIS OF CHOLESTEROL IN IMMUNE COMPLEXES | 2013 |
|
RU2538685C1 |
METHOD FOR DYSTONIA SIMULATION IN RATS BY HYPOTENSIVE TYPE | 2014 |
|
RU2614521C2 |
INSTANT METHOD FOR ASSESSING ATHEROGENICITY OF IMMUNE COMPLEXES OF HUMAN BLOOD SERUM | 2013 |
|
RU2549466C1 |
Authors
Dates
2016-07-20—Published
2015-01-15—Filed